Management of endometriosis-associated pain

Clinical Obstetrics and Gynecology

Volumn 53, Issue 2, 2010, Pages 439-448

  Hansen, Keith A ^a   Chalpe, Abha ^a   Eyster, Kathleen M ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Endometriosis; Hysterectomy; Laparoscopy; Medical therapies; Pelvic pain; Surgery

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; DANAZOL; ESTROGEN; ETHINYLESTRADIOL; ETONOGESTREL; GESTAGEN; GONADORELIN AGONIST; INFLIXIMAB; LETROZOLE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; NERVE GROWTH FACTOR; NORETHISTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PENTOXIFYLLINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROGESTERONE; PROGESTERONE RECEPTOR MODULATOR; ROFECOXIB; ROSIGLITAZONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TUMOR NECROSIS FACTOR ALPHA; TZE 5323; UNCLASSIFIED DRUG; VITAMIN D; GONADORELIN;

ARTHRALGIA; BLEEDING; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DEPRESSION; DISEASE ASSOCIATION; DYSMENORRHEA; DYSPAREUNIA; ENDOMETRIOSIS; HUMAN; HYSTERECTOMY; INTERMETHOD COMPARISON; INTRAUTERINE CONTRACEPTIVE DEVICE; IRREGULAR BLEEDING; LAPAROSCOPIC SURGERY; LIBIDO DISORDER; MUSCLE CRAMP; NEURECTOMY; NOCICEPTIVE RECEPTOR; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; PAIN; PELVIS PAIN SYNDROME; PHARMACOGENOMICS; RECURRENT DISEASE; REVIEW; SALPINGOOOPHORECTOMY; SIDE EFFECT; SPOTTING; TRANSDERMAL PATCH; TREATMENT DURATION; TREATMENT RESPONSE; VAGINA BLEEDING; VAGINA RING; VAGINAL DRYNESS; VASOMOTOR DISORDER; WEIGHT GAIN; COMPLICATION; EVIDENCE BASED MEDICINE; FEMALE; LAPAROSCOPY; MULTIMODALITY CANCER THERAPY; OVARIECTOMY; PAIN MEASUREMENT; PELVIC PAIN; PREGNANCY; PROCEDURES; TREATMENT OUTCOME;

AROMATASE INHIBITORS; COMBINED MODALITY THERAPY; CONTRACEPTIVES, ORAL; DANAZOL; ENDOMETRIOSIS; EVIDENCE-BASED MEDICINE; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYSTERECTOMY; LAPAROSCOPY; OVARIECTOMY; PAIN MEASUREMENT; PELVIC PAIN; PREGNANCY; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TREATMENT OUTCOME;

EID: 77951953835     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3181dbda06     Document Type: Review

References (40)

1. Martin DC, Hubert GP, Van der Zwaag R, et al. Laparoscopic appearances of peritoneal endometriosis. Fertil Steril. 1989;51:63-67.
2. Bulun SE. Endometriosis. NEJM. 2009;360:268-279.
3. Ozawa Y, Murakami T, Erada Y, et al. Management of the pain associated with endometriosis: an update of the painful problems. Tohoku J Exp Med. 2006;210:175-188.
4. Vincent K, Kennedy S, Stratton P. Pain scoring in endometriosis: entry criteria and outcome measures for clinical trials. Report from the Art and Science of Endometriosis meeting. Fertil Steril. 2010;93:62-67.
5. The Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis. Fertil Steril. 2006;86: S18-S27.
6. Berkley KJ, Rapkin AJ, Papka RE. The pains of endometriosis. Science. 2005;308:1587-1589.
7. Tokushige N, Markham R, Russell P, et al. High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis. Hum Reprod. 2006;21:782-787.
8. Eyster KM, Klinkova O, Kennedy V, et al. Whole genomic deoxyribonucleic acid microarray analysis of gene expression in ectopic versus eutopic endometrium. Fertil Steril. 2007;88:1505-1533.
9. Sutton CJ, Ewen SP, Whitelaw N, et al. Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis. Fertil Steril. 1994;62:696-700.
10. Abbott J, Hawe J, Hunter D, et al. Laparoscopic excision of endometriosis: a randomized, placebo-controlled trial. Fertil Steril. 2004;82:878-884.
11. Valle RF, Sciarra JJ. Endometriosis: treatment strategies. Ann N Y Acad Sci. 2003;997:229-239.
12. Hart RJ, Hickey M, Maouris P, et al. Excisional surgery versus ablative surgery for ovarian endometriomata (Cochrane Review). Cochrane Database Syst Rev. 2008;2: CD004992.
13. Kennedy S, Bergqvist A, Chapron C, et al; Saridogan E on behalf of ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005;20:2698-2704.
14. Proctor ML, Latthe PM, Farquhar CM, et al. Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea (Cochrane Review). Cochrane Database Syst Rev. 2005;4: CD001896.
15. Namnoum AB, Hickman TN, Goodman SB, et al. Incidence of symptom recurrence after hysterectomy for endometriosis. Fertil Steril. 1995;64:898-902.
16. Matorras R, Elorriaga MA, Pijoan JI, et al. Recurrence of endomeriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy. Fertil Steril. 2002;77:303-308.
17. Winkel CA. A cost-effective approach to the management of endometriosis. Curr Opin Obstet Gynecol. 2000;12:317-320.
18. Selak V, Farquhar C, Prentice A, et al. Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst Rev. 2007;4: CD000068.
19. Prentice A, Deary AJ, Bland E. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev. 2000;2: CD002122.
20. Davis LJ, Kennedy SS, Moore J, et al. Oral contraceptives for pain associated with endometriosis (Cochrane Review). Cochrane Database Syst Rev. 2007;3: CD001019.
21. Surrey E, Hornstein MD. Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: longterm follow-up. Obstet Gynecol. 2002;99:709-719.
22. Kupker W, Felberbaum RE, Krap M, et al. Use of GnRH antagonists in the treatment of endometriosis. Reprod BioMed Online. 2002;5:13-16.
23. Vercellini P, Aimi G, Paonazza S, et al. A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study. Fertil Steril. 1999;72:505-508.
24. Vercellini P, Frontino G, De Giorgi O, et al. Comparison of a levonorgestrelreleasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study. Fertil Steril. 2003;80:305-309.
25. Cobellis L, Razzi S, Fava A, et al. A danazol-loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis. Fertil Steril. 2004;82:239-240.
26. Vercellini P, Barbara G, Somigliana E, et al. Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis. Fertil Steril. 2009. [Epub ahead of print].
27. Rose PG, Alvarez B, Maclennan GT. Exacerbation of endometriosis as a result of premenopausal tamoxifen exposure. Am J Obstet Gynecol. 2000;183:507-508.
28. Saito T, Yaoshizawa M, Yamauchi Y, et al. Effects of the novel orally active antiestrogen TZE-5323 on experimental endometriosis. Arzneimittelforschung/Drug Res. 2003;53:507-514.
29. Kettel LM, Murphy AA, Morales AJ, et al. Treatment of endometriosis with the antiprogesterone mifepristone (RU 486). Fertil Steril. 1996;65:23.
30. Chwalisz K, Perez MC, DeManno D, et al. Selective progesterone receptor modulator (SPRM) development and use in the treatment of leiomyomata and endometriosis. Endo Reviews. 2005;26:423-438.
31. Takayama K, Zeitoun K, Gunby RT, et al. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril. 1998;69:709-713.
32. Shippen ER, West WJ. Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor. Fertil Steril. 2004;81:1395-1398.
33. Ailawadi R, Jobanputra S, Kataria M, et al. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil Steril. 2004;81:290-296.
34. Kamencic H, Thiel JA. Pentoxifylline after conservative surgery for endometriosis: a randomized, controlled trial. J Min Invasive Gynecol. 2008;15:62-66.
35. Lv D, Song H, Li Y, et al. Pentoxifylline versus medical therapies for subfertile women with endometriosis (Cochrane Review). Cochrane Database Syst Rev. 2009;3: CD007677.
36. D'Hooghe TM, Nugent NP, Cuneo S, et al. Recombinant human TNFRSF1A (r-hTBP1) inhibits the development of endometriosis in baboons: a prospective, randomized, placebo-and drug-controlled study. Biol Reprod. 2006;74:131-136.
37. Koninckx PR, Craessaerts M, Timmerman D, et al. Anti-TNF-a treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial. Hum Reprod. 2008;23:2017-2023.
38. McKinnon B, Bersinger NA, Huber AW, et al. PPAR-g expression in peritoneal endometriotic lesions correlates with pain experienced by patients. Fertil Steril. 2010;93:293-296.
39. Lebovic DI, Mwenda JM, Chai DC, et al. PPAR-gamma receptor ligand induces regression of endometrial explants in baboons: a prospective, randomized, placebo-and drug-controlled study. Fertil Steril. 2007;88 (suppl 2) : 1108-1119.
40. Moravek MB, Ward EA, Lebovic DI. Thiazolidinediones as therapy for endometriosis: a case series. Gynecol Obstet Invest. 2009;68:167-170.